医学
单克隆抗体
内科学
CD38
多发性骨髓瘤
肿瘤科
抗体
病毒学
癌症研究
免疫学
川地34
干细胞
遗传学
生物
作者
Gary J. Schiller,Brea Lipe,Nizar J. Bahlis,Sascha A. Tuchman,William Bensinger,Heather J. Sutherland,Suzanne Lentzsch,Muhamed Baljević,Darrell White,Rami Kotb,Christine I. Chen,Adriana Rossi,Noa Biran,Richard LeBlanc,Sebastian Grosicki,Maurizio Martelli,Eberhard Gunsilius,Ivan Špıčka,Don A. Stevens,Thierry Façon
标识
DOI：10.1016/j.clml.2023.06.001
摘要
Selinexor-based regimens may offer effective and well-tolerated therapy to patients with relapsed and/or refractory MM who had disease previously exposed or refractory to αCD38 mAb therapy and could help address the unmet clinical need in these high-risk patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
你嵙这个期刊没买
GingerF
嘻嘻哈哈
mashibeo
ccm
pluto
VDC
YifanWang
遇上就这样吧
Tourist
竹筏过海
soler
梅天豪
悲凉的冬天
无极微光
wlscj
Criminology34
北地风情
兼听则明
Leonard
avalanche
GPTea
liao
皖公网安备34019202002308
